查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1756389

細胞和基因治療生物分析測試服務市場，按產品類型、按測試類型、按技術、按適應症覆蓋範圍、按最終用戶、按國家/地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Cell & Gene Therapy Bioanalytical Testing Services Market, By Product Type, By Test Type, By Technology, By Indication Coverage, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年細胞和基因治療生物分析測試服務市場規模價值 5.609 億美元，2025 年至 2032 年的複合年成長率為 7.90%。

細胞和基因治療生物分析測試服務市場-市場動態

臨床試驗數量增加和監管審查力度加大，加速市場擴張

臨床試驗活動的激增和監管機構對先進療法的日益關注，顯著增加了對細胞和基因治療生物分析測試服務的需求。 2023 年，美國 FDA 批准了超過 25 項基因療法的新藥臨床試驗申請 (IND)，反映出正在評估的療法數量眾多。此外，歐洲藥品管理局 (EMA) 和日本藥品醫療器材綜合機構 (PMDA) 等監管機構也擴大要求進行全面的生物分析驗證，以確保安全性和有效性。美國國立衛生研究院 (NIH) 和加州再生醫學研究所 (CIRM) 等組織增加了對基因和細胞試驗的資助，間接刺激了對專業測試服務的需求。這些趨勢強調了高精度分析平台在確保資料完整性方面的關鍵作用，這對於治療成功和市場授權至關重要，尤其是在監管日益嚴格和創新驅動的環境中。

細胞和基因治療生物分析測試服務市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 7.90%

根據產品類型細分，預計細胞療法將在 2024 年佔據最大市場佔有率

根據測試類型細分，生物利用度和生物等效性是 2024 年領先的測試類型

根據技術細分，次世代定序 (NGS) 是 2024 年的領先技術

根據適應症覆蓋範圍細分，腫瘤癌症是 2024 年領先的適應症覆蓋範圍

根據最終用戶細分，生物技術和製藥公司是 2024 年領先的最終用戶

按地區分類，北美是 2024 年的主要收入來源

細胞和基因治療生物分析測試服務市場-細分分析：

全球細胞和基因療法生物分析測試服務市場根據產品類型、測試類型、技術、適應症覆蓋範圍、最終用戶和地區進行細分。

根據產品類型，市場分為三類：細胞療法、基因療法（體外和體內）以及基因修飾細胞療法（CAR-T細胞療法、CAR-NK細胞療法、TCR-T細胞療法）。細胞療法服務著重於幹細胞和免疫細胞的效力、身份和安全性測試。基因療法分為體外和體內兩種模式，需要進行病毒載體和轉導效率分析。 CAR-T、CAR-NK和TCR-T等基因修飾細胞療法著重於工程化免疫反應進行生物分析驗證。

根據測試類型，市場分為八類：生物利用度和生物等效性研究、藥物動力學測試、藥效動力學測試、生物標記測試、非臨床、組織生物分析、雜項和其他。生物利用度和生物等效性研究確保治療的一致性，而藥物動力學和藥效動力學測試則評估吸收和藥物作用。生物標記測試支持療效追蹤，非臨床和組織生物分析則有助於臨床前洞察。雜項和其他測試提供支持性、針對特定病例的分析資料。

細胞和基因治療生物分析測試服務市場-地理洞察

細胞與基因療法生物分析測試服務市場呈現顯著的地理差異，受各地區療法開發速度、監管框架和研發資金的影響。北美憑藉其先進的生物技術中心、強大的政府支持以及創新療法的早期應用，在市場佔有率方面處於領先地位。尤其是美國，它擁有密集的基因和細胞治療開發商網路，並制定了諸如FDA加速途徑等監管框架，鼓勵臨床擴展。歐洲緊隨其後，德國、英國和荷蘭等國家正在投資建造GMP認證實驗室和國家細胞治療計畫。亞太地區正迅速崛起，成為一個強力的競爭者，尤其是在中國、韓國和日本，這些國家政府支持的生物科技園區和不斷擴大的臨床基礎設施支撐著市場的成長。印度和新加坡日益成長的外包趨勢也在重塑區域服務格局，使亞洲成為經濟高效的生物分析測試服務的戰略中心。

細胞和基因治療生物分析測試服務市場-競爭格局：

細胞與基因治療生物分析測試服務市場的競爭格局以全球合約研究組織 (CRO)、專業測試實驗室以及專注於提升複雜生物製劑分析能力的新興生物技術服務提供者為標誌。主要參與者正在投資最先進的設施、GLP/GMP 認證實驗室和專有檢測平台，以滿足日益成長的監管和科研需求。療法開發商與 CRO 之間的合作日益增多，旨在簡化流程並確保從臨床前階段到臨床開發階段的合規性。各公司正在擴展服務組合，涵蓋客製化效力檢測、生物分佈研究、載體表徵以及基於新一代定序的分析。此外，學術實驗室和醫院附屬實驗室正在為早期方法開發和標準化做出貢獻。在亞太等地區，競爭也日益激烈，當地公司正在擴大全球試驗服務，使靈活性、監管專業知識和周轉時間成為這一不斷變化的格局中的關鍵差異化因素。

最新動態：

2024 年 8 月，SGS 在北美推出了針對細胞和基因治療的專業生物分析測試服務，在其位於新罕布夏州哈德遜的實驗室提供從發現到 3 期臨床試驗的全面解決方案，擴大了先進治療開發和法規遵從性的全球能力。

2025年3月，Bharat Biotech在特倫甘納邦啟動了其首個細胞和基因治療設施，投資7,500萬美元。該公司的目標是在2028年推出針對腫瘤和罕見疾病的新型細胞和基因療法，重點是可負擔性，並拓展疫苗以外的領域。

2025 年 4 月，Cell Therapies 和 Xellera Therapeutics 合作加速亞太地區細胞和基因治療的獲取，重點關注澳洲和香港的 GMP 製造、監管解決方案和協作創新，旨在加強患者護理並簡化市場准入。

目錄

第1章：細胞和基因治療生物分析測試服務市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 細胞和基因治療生物分析測試服務市場片段（按產品類型）
    • 細胞和基因治療生物分析測試服務市場片段（按測試類型）
    • 細胞和基因治療生物分析測試服務市場片段（按技術）
    • 細胞和基因治療生物分析測試服務市場片段（按適應症覆蓋範圍）
    • 細胞和基因治療生物分析測試服務市場片段（按最終用戶）
    • 細胞和基因治療生物分析測試服務市場（按國家/地區）
    • 細胞和基因治療生物分析測試服務市場片段（按地區）
  • 競爭洞察

第3章：細胞和基因治療生物分析測試服務主要市場趨勢

  • 細胞和基因治療生物分析測試服務市場促進因素
    • 市場促進因素的影響分析
  • 細胞和基因治療生物分析測試服務市場限制
    • 市場限制的影響分析
  • 細胞和基因治療生物分析測試服務市場機會
  • 細胞和基因治療生物分析測試服務市場未來趨勢

第4章：細胞與基因治療生物分析測試服務業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：細胞與基因治療生物分析測試服務市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：細胞與基因治療生物分析測試服務市場格局

  • 細胞和基因治療生物分析測試服務市場佔有率分析（2024年）
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：細胞和基因治療生物分析測試服務市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 細胞療法
    • 基因治療
      • 離體
      • 體內
    • 基因改造細胞療法
      • CAR-T細胞療法
      • CAR-NK細胞療法
      • TCR-T細胞療法

第8章：細胞和基因治療生物分析測試服務市場 - 按測試類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 生物利用度和生物等效性研究
    • 藥物動力學測試
    • 藥效動力學測試
    • 生物標記檢測
    • 非臨床
    • 組織生物分析
    • 各種各樣的
    • 其他

第9章：細胞和基因治療生物分析測試服務市場 - 按技術

  • 概述
    • 按技術細分的市場佔有率分析
    • 聚合酶連鎖反應
    • 酵素連結免疫吸附試驗
    • 下一代定序（NGS）
    • 流式細胞儀
    • 其他

第 10 章：細胞和基因治療生物分析測試服務市場 - 按適應症覆蓋範圍

  • 概述
    • 按適應症覆蓋率分析細分市場佔有率
    • 腫瘤學 癌症
    • 傳染病
    • 神經系統疾病
    • 心血管疾病
    • 胃腸道疾病
    • 自體免疫疾病
    • 罕見疾病
    • 其他

第 11 章：細胞和基因治療生物分析測試服務市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 生技與製藥公司
    • 學術及研究機構
    • 合約研究組織（CRO）

第 12 章：細胞和基因治療生物分析測試服務市場-按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美細胞和基因治療生物分析測試服務主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模及預測（按適應症覆蓋範圍）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲細胞和基因治療生物分析測試服務主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模及預測（依適應症覆蓋）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區細胞和基因治療生物分析測試服務主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品類型）
    • 亞太地區市場規模及預測（依測試類型）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（依適應症覆蓋範圍）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲細胞和基因治療生物分析測試服務主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品類型）
    • 拉丁美洲市場規模及預測（按測試類型）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模及預測（依適應症覆蓋範圍）
    • LATAM 規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲細胞和基因治療生物分析測試服務主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按測試類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按適應症覆蓋範圍）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 13 章：關鍵供應商分析-細胞和基因治療生物分析測試服務產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Alliance Pharma
    • BioAgilytix Labs
    • Charles River Laboratories
    • Clean Cells
    • Covance Inc.
    • Eurofins Scientific
    • ICON plc
    • Intertek Group Plc
    • IQVIA, Inc.
    • KCAS Bioanalytical Services
    • Laboratory Corporation of America Holdings
    • Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
    • Pharmaron
    • Prolytix
    • SGS SA
    • Syneos Health
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5304

REPORT HIGHLIGHT

Cell & Gene Therapy Bioanalytical Testing Services Market size was valued at US$ 560.90 Million in 2024, expanding at a CAGR of 7.90% from 2025 to 2032.

The Cell & Gene Therapy Bioanalytical Testing Services Market encompasses specialized analytical services that support the development, characterization, and regulatory approval of cell and gene therapy products. Growth in this market is propelled by the rising number of clinical trials in regenerative medicine and personalized therapeutics. For instance, as of early 2024, the FDA had over 2,000 active Investigational New Drug applications for gene and cell therapy products. Increasing investments from public health bodies, like the NIH's \$500 million commitment to advance gene therapy for rare diseases, further bolster demand. However, the complexity of assay development and high operational costs remain key restraints. Opportunities lie in expanding testing capabilities for viral vectors, potency assays, and biodistribution studies, especially as global regulatory agencies tighten guidelines for cell-based therapies. Additionally, partnerships between biopharma and CROs are streamlining bioanalytical workflows to enhance speed-to-market for next-gen therapies.

Cell & Gene Therapy Bioanalytical Testing Services Market- Market Dynamics

Rising Clinical Trial Volume and Regulatory Scrutiny to Accelerate Market Expansion

The surge in clinical trial activity and growing regulatory focus on advanced therapies have significantly intensified the demand for cell and gene therapy bioanalytical testing services. In 2023, the U.S. FDA approved over 25 Investigational New Drug (IND) applications for gene therapies, reflecting the robust pipeline of therapies under evaluation. Furthermore, regulatory bodies like the European Medicines Agency (EMA) and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan are increasingly mandating comprehensive bioanalytical validation for safety and efficacy assurance. Organizations such as the NIH and CIRM (California Institute for Regenerative Medicine) have increased funding for gene and cell-based trials, indirectly fueling demand for specialized testing services. These trends emphasize the critical role of high-precision analytical platforms in ensuring data integrity, which is vital for therapeutic success and market authorization, particularly in a landscape that is becoming more regulated and innovation-driven.

Cell & Gene Therapy Bioanalytical Testing Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.90% over the forecast period (2025-2032)

Based on product type segmentation, Cell therapy was predicted to show maximum market share in the year 2024

Based on Test Type segmentation, Bioavailability & bioequivalence was the leading Test Type in 2024

Based on Technology segmentation, Next-Generation Sequencing (NGS) was the leading Technology in 2024

Based on Indication Coverage segmentation, Oncology Cancer was the leading Indication Coverage in 2024

Based on end user segmentation, Biotechnology & Pharmaceutical Companies were the leading end user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Cell & Gene Therapy Bioanalytical Testing Services Market- Segmentation Analysis:

The Global Cell & Gene Therapy Bioanalytical Testing Services Market is segmented on the basis of Product Type, Test Type, Technology, Indication Coverage, End User, and Region.

The market is divided into three categories based on product type: Cell Therapy, Gene Therapy (Ex-vivo, and In-vivo), and Gene-Modified Cell Therapy (CAR T-cell therapies, CAR-NK cell therapy, TCR-T cell therapy). Cell therapy services focus on potency, identity, and safety testing for stem and immune cells. Gene therapy is segmented into ex-vivo and in-vivo modalities, requiring viral vector and transduction efficiency assays. Gene-modified cell therapies like CAR T, CAR-NK, and TCR-T emphasize bioanalytical validation for engineered immune responses.

The market is divided into eight categories based on Test Type: Bioavailability & Bioequivalence Studies, Pharmacokinetic Testing, Pharmacodynamic Testing, Biomarker Testing, Non-clinical, Tissue Bioanalysis, Miscellaneous, and Others. Bioavailability & bioequivalence studies ensure therapeutic consistency, while pharmacokinetic and pharmacodynamic testing assess absorption and drug action. Biomarker testing supports efficacy tracking, and non-clinical and tissue bioanalysis aid preclinical insights. Miscellaneous and other tests provide supportive, case-specific analytical data.

Cell & Gene Therapy Bioanalytical Testing Services Market- Geographical Insights

The Cell & Gene Therapy Bioanalytical Testing Services Market shows significant geographical variation, driven by the pace of therapy development, regulatory frameworks, and R&D funding across regions. North America leads in market share due to the presence of advanced biotechnology hubs, strong government support, and early adoption of innovative therapies. The U.S., in particular, has a dense network of gene and cell therapy developers and regulatory frameworks such as the FDA's accelerated pathways, encouraging clinical expansion. Europe follows closely, with countries like Germany, the UK, and the Netherlands investing in GMP-certified labs and national cell therapy initiatives. Asia-Pacific is rapidly emerging as a strong contender, especially in China, South Korea, and Japan, where government-backed biotech parks and expanding clinical infrastructure support growth. Increasing outsourcing trends in India and Singapore are also reshaping the regional service landscape, making Asia a strategic hub for cost-effective bioanalytical testing services.

Cell & Gene Therapy Bioanalytical Testing Services Market- Competitive Landscape:

The competitive landscape of the Cell & Gene Therapy Bioanalytical Testing Services Market is marked by the presence of global contract research organizations (CROs), specialized testing labs, and emerging biotech service providers focused on advancing analytical capabilities for complex biologics. Key players are investing in state-of-the-art facilities, GLP/GMP-certified labs, and proprietary assay platforms to meet growing regulatory and scientific demands. Collaborations between therapy developers and CROs are increasing, aiming to streamline timelines and ensure regulatory compliance from preclinical stages through clinical development. Companies are expanding service portfolios to include customized potency assays, biodistribution studies, vector characterization, and next-generation sequencing-based analytics. Moreover, academic and hospital-affiliated labs are contributing to early-stage method development and standardization. Competition is also intensifying in regions like Asia-Pacific, where local firms are scaling up offerings for global trials, making flexibility, regulatory expertise, and turnaround time key differentiators in this evolving landscape.

Recent Developments:

In August 2024, SGS launched specialized bioanalytical testing services for cell and gene therapy in North America, offering comprehensive solutions from discovery to phase 3 clinical trials at its Hudson, New Hampshire lab, expanding global capabilities for advanced therapeutic development and regulatory compliance.

In March 2025, Bharat Biotech launched its first cell and gene therapy facility in Telangana, investing $75 million. The company aims to introduce novel cell and gene therapies for oncology and rare diseases by 2028, focusing on affordability and expanding beyond vaccines.

In April 2025, Cell Therapies and Xellera Therapeutics partnered to accelerate cell and gene therapy access across Asia-Pacific, focusing on GMP manufacturing, regulatory solutions, and collaborative innovation in Australia and Hong Kong, aiming to enhance patient care and streamline market access.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Alliance Pharma
  • BioAgilytix Labs
  • Charles River Laboratories
  • Clean Cells
  • Covance Inc.
  • Eurofins Scientific
  • ICON plc
  • Intertek Group Plc
  • IQVIA, Inc.
  • KCAS Bioanalytical Services
  • Laboratory Corporation of America Holdings
  • Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
  • Pharmaron
  • Prolytix
  • SGS SA
  • Syneos Health
  • Others

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cell Therapy
  • Gene Therapy
  • Ex-vivo
  • In-vivo
  • Gene-Modified Cell Therapy
  • CAR T-cell therapies
  • CAR-NK cell therapy
  • TCR-T cell therapy

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Bioavailability & Bioequivalence Studies
  • Pharmacokinetic Testing
  • Pharmacodynamic Testing
  • Biomarker Testing
  • Non-clinical
  • Tissue Bioanalysis
  • Miscellaneous
  • Others

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR
  • ELISA
  • Next-Generation Sequencing (NGS)
  • Flow Cytometry
  • Others

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY INDICATION COVERAGE- MARKET ANALYSIS, 2019 - 2032

  • Oncology Cancer
  • Infectious Diseases
  • Neurological disorders
  • Cardiovascular Disorders
  • Gastrointestinal Diseases
  • Autoimmune Diseases
  • Rare Diseases
  • Others

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

GLOBAL CELL & GENE THERAPY BIOANALYTICAL TESTING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell & Gene Therapy Bioanalytical Testing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Product Type
    • 2.1.2. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Test Type
    • 2.1.3. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Technology
    • 2.1.4. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Indication Coverage
    • 2.1.5. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by End User
    • 2.1.6. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Country
    • 2.1.7. Cell & Gene Therapy Bioanalytical Testing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell & Gene Therapy Bioanalytical Testing Services Key Market Trends

  • 3.1. Cell & Gene Therapy Bioanalytical Testing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell & Gene Therapy Bioanalytical Testing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell & Gene Therapy Bioanalytical Testing Services Market Opportunities
  • 3.4. Cell & Gene Therapy Bioanalytical Testing Services Market Future Trends

4. Cell & Gene Therapy Bioanalytical Testing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell & Gene Therapy Bioanalytical Testing Services Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cell & Gene Therapy Bioanalytical Testing Services Market Landscape

  • 6.1. Cell & Gene Therapy Bioanalytical Testing Services Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell & Gene Therapy Bioanalytical Testing Services Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Cell Therapy
    • 7.1.3. Gene Therapy
      • 7.1.3.1. Ex-vivo
      • 7.1.3.2. In-vivo
    • 7.1.4. Gene-Modified Cell Therapy
      • 7.1.4.1. CAR T-cell therapies
      • 7.1.4.2. CAR-NK cell therapy
      • 7.1.4.3. TCR-T cell therapy

8. Cell & Gene Therapy Bioanalytical Testing Services Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 8.1.2. Bioavailability & Bioequivalence Studies
    • 8.1.3. Pharmacokinetic Testing
    • 8.1.4. Pharmacodynamic Testing
    • 8.1.5. Biomarker Testing
    • 8.1.6. Non-clinical
    • 8.1.7. Tissue Bioanalysis
    • 8.1.8. Miscellaneous
    • 8.1.9. Others

9. Cell & Gene Therapy Bioanalytical Testing Services Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. PCR
    • 9.1.3. ELISA
    • 9.1.4. Next-Generation Sequencing (NGS)
    • 9.1.5. Flow Cytometry
    • 9.1.6. Others

10. Cell & Gene Therapy Bioanalytical Testing Services Market - By Indication Coverage

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Indication Coverage, 2024 & 2032 (%)
    • 10.1.2. Oncology Cancer
    • 10.1.3. Infectious Diseases
    • 10.1.4. Neurological disorders
    • 10.1.5. Cardiovascular Disorders
    • 10.1.6. Gastrointestinal Diseases
    • 10.1.7. Autoimmune Diseases
    • 10.1.8. Rare Diseases
    • 10.1.9. Others

11. Cell & Gene Therapy Bioanalytical Testing Services Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Biotechnology & Pharmaceutical Companies
    • 11.1.3. Academic & Research Institutes
    • 11.1.4. Contract Research Organizations (CROs)

12. Cell & Gene Therapy Bioanalytical Testing Services Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Cell & Gene Therapy Bioanalytical Testing Services Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Indication Coverage, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Cell & Gene Therapy Bioanalytical Testing Services Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Alliance Pharma
    • 13.2.2. BioAgilytix Labs
    • 13.2.3. Charles River Laboratories
    • 13.2.4. Clean Cells
    • 13.2.5. Covance Inc.
    • 13.2.6. Eurofins Scientific
    • 13.2.7. ICON plc
    • 13.2.8. Intertek Group Plc
    • 13.2.9. IQVIA, Inc.
    • 13.2.10. KCAS Bioanalytical Services
    • 13.2.11. Laboratory Corporation of America Holdings
    • 13.2.12. Pharmaceutical Product Development, Inc. (Thermo Fisher Scientific Inc.)
    • 13.2.13. Pharmaron
    • 13.2.14. Prolytix
    • 13.2.15. SGS SA
    • 13.2.16. Syneos Health
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us